Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

The LHCGR rs2293275 Variant, the Gonadorelin Pathway, and Reproductive Health: What Your Genotype May Mean

Gonadorelin is a synthetic version of GnRH, a hormone made by the hypothalamus that helps control the brain-to-gonad communication system called the HPG axis. This pathway signals the pituitary gland to release LH and FSH, which support key reproductive functions such as testosterone production, egg maturation, ovulation, and sperm development. The LHCGR gene makes the receptor for LH in ovarian and testicular tissue, so it helps carry out these signals. Natural genetic differences in LHCGR may affect how strongly reproductive tissues respond to LH, which can influence hormone balance and fertility-related processes.

Genetic variation in the LHCGR gene may influence how efficiently the biological processes connected to Gonadorelin and Reproductive Health function. The rs2293275 variant is analyzed in the PlexusDx Precision Peptide Genetic Test as part of the Reproductive Health pathway. Depending on your genotype, this variant may have a modest to meaningful influence on hormonal regulation, fertility signaling, and reproductive resilience. Understanding your result gives you a personalized starting point for targeted lifestyle, dietary, and supplement strategies grounded in your unique biology.

Practical Foundations for Everyone

Regardless of your LHCGR rs2293275 genotype, the following lifestyle inputs consistently support hormonal balance, reproductive function, and endocrine health. Carriers of the effect allele often notice a stronger return on these habits when applied consistently — which makes regularity more valuable than intensity.

  • Consistent nutrition: A whole-food dietary pattern rich in vegetables, quality protein, healthy fats, and fiber provides the micronutrient foundation that supports reproductive health-related pathways at a cellular level.
  • Regular movement: Physical activity — particularly a combination of aerobic exercise and resistance training — supports the metabolic signaling and growth factor pathways that interact with reproductive health and biological resilience.
  • Quality sleep: Restorative sleep is essential for cellular repair, hormone regulation, and the metabolic processes that underpin reproductive health. Consistent sleep timing amplifies the benefits of other lifestyle habits.
  • Stress management: Chronic stress elevates cortisol and inflammatory markers that can blunt the efficiency of pathways related to reproductive health. A daily stress-reduction practice — even five to ten minutes of slow breathing or mindfulness — helps maintain biological balance.

Diet Recommendations for LHCGR rs2293275 and the Gonadorelin Pathway

A targeted nutritional approach for the LHCGR rs2293275 variant focuses on supplying the micronutrients and macronutrient balance that support hormonal regulation, fertility signaling, and reproductive resilience and reduce the metabolic burden on pathways connected to Gonadorelin. Priority nutrients vary by pathway but consistently center on anti-inflammatory whole foods, adequate protein for cellular and tissue support, and micronutrient density from colorful produce and quality fats.

The Mediterranean Diet is designed to support this pathway. Our Mediterranean Diet is built with high-fiber, nutrient-dense foods including fruits, vegetables, legumes, and whole grains. Heart-healthy fats are provided by olive oil, avocados, nuts and seeds. Quality protein from dairy, poultry and fish is also consumed to round out the di...

Build meals around quality protein sources (fish, poultry, legumes, eggs), fiber-rich carbohydrates (vegetables, whole grains, legumes), and healthy fats (olive oil, avocado, nuts, seeds). Minimize ultra-processed foods, excessive added sugars, and alcohol — all of which increase oxidative and inflammatory burden on pathways that interact with reproductive health and Gonadorelin-related signaling.

Supplement Considerations for LHCGR rs2293275 Support

Supplements cannot modify your LHCGR rs2293275 genotype, but targeted supplementation can address nutritional gaps and support the biological pathways connected to Gonadorelin and reproductive health. A foundations-first approach — prioritizing the basics before adding specialty products — produces the most consistent outcomes. Always discuss supplementation with your healthcare provider before starting, especially if you take medications or manage ongoing health conditions.

The PlexusDx Nutrient Support is a personalized daily pack designed to support this pathway. PlexusDx Nutrient Support is a personalized daily pack with a multivitamin, Omega-3, and a 10B probiotic to help fill nutrient gaps, support heart and brain health, and promote digestive and immune balance. Convenient and easy to take, it simplifies your daily wellness routine in...

Key nutrients commonly relevant to the Reproductive Health pathway include those that support hormonal regulation, fertility signaling, and reproductive resilience. Assess dietary gaps first; targeted supplementation is most valuable when it addresses a specific nutritional shortfall confirmed by food tracking or lab results rather than used as a substitute for consistent lifestyle habits.

Lifestyle Recommendations for Reproductive Health and Gonadorelin Pathway Support

Consistent lifestyle habits are the most durable and evidence-supported way to reinforce the biological pathways associated with Gonadorelin and reproductive health. For carriers of the LHCGR rs2293275 effect allele, these habits tend to produce a more noticeable return because they directly influence the signaling environments where the variant has its greatest impact.

A practical weekly target is 150 minutes or more of moderate aerobic activity combined with two to three resistance training sessions. Sleep consistency — a fixed wake time, morning outdoor light, and a 60 to 90 minute wind-down before bed — supports cellular recovery and the hormonal balance that underpins reproductive health. Stress management practices such as slow breathing, mindfulness, or low-stimulation outdoor time help maintain the biological stability that Gonadorelin-related pathways depend on for efficient function. Avoiding chronic sleep debt, late-day caffeine, and excessive alcohol further removes common suppressors of reproductive health-related signaling.

Genetic Interpretations for rs2293275 (LHCGR)

2 Effect Alleles: TT (+/+)

You have the TT genotype for rs2293275 which means you carry two copies of the effect allele. This variation is associated with altered LH receptor signaling, and in some studies has been linked to differences in how strongly reproductive tissues respond to luteinizing hormone stimulation. In the context of the gonadorelin pathway, this is relevant because gonadorelin acts upstream by stimulating release of LH from the pituitary, while the receptor encoded by LHCGR helps determine how effectively that LH signal is translated into downstream reproductive effects in the ovaries or testes. Research on rs2293275 suggests this variant may influence receptor function, trafficking, or signaling efficiency, which could contribute to differences in testosterone production, ovulatory signaling, follicular maturation, or broader reproductive hormone balance. Some studies have associated the functional variant with reproductive phenotypes such as altered ovarian response or endocrine differences, although results across populations are mixed and should be interpreted cautiously. From a practical standpoint, this genotype may make overall HPG-axis support especially important, including adequate calorie intake, sufficient protein, healthy dietary fats, zinc, selenium, vitamin D, resistance exercise without chronic overtraining, stress management, and consistent sleep. This genotype does not diagnose a fertility problem or hormone disorder, but it may reflect a somewhat less typical downstream LH-response pattern within the broader gonadorelin signaling cascade.

1 Effect Allele: TC (+/-)

You have the TC genotype for rs2293275, which means you carry one copy of the effect allele and one copy of the non-effect allele. This intermediate genotype may be associated with a moderate change in LH receptor responsiveness, often representing a middle-ground signaling pattern between the two homozygous genotypes. In connection with the gonadorelin pathway, this suggests that once gonadorelin stimulates LH release, the downstream response at the receptor level may be slightly modified but is often still reasonably functional. Because LHCGR helps mediate LH-driven processes such as testosterone synthesis in Leydig cells, ovulation-related signaling, and ovarian steroid production, even modest variation in receptor activity may contribute to subtle differences in reproductive endocrine physiology. The practical takeaway is usually not that the pathway is impaired, but that hormone signaling efficiency may be somewhat more influenced by lifestyle and physiologic context, including sleep quality, metabolic health, nutrient status, inflammation, and chronic stress. A supportive approach may include maintaining healthy body composition, avoiding severe dieting or overtraining, ensuring adequate intake of protein and essential fats, and paying attention to micronutrients involved in reproductive health such as zinc, selenium, magnesium, and vitamin D. This genotype is best viewed as a marker of potentially intermediate receptor behavior rather than a stand-alone predictor of sexual or reproductive outcomes.

0 Effect Alleles: CC (-/-)

You have the CC genotype for rs2293275 which means you carry two copies of the non-effect allele. This genotype is generally associated with typical LH receptor signaling and a more standard downstream response to luteinizing hormone. In the context of the gonadorelin pathway, this suggests that after gonadorelin-related signaling stimulates LH release from the pituitary, the receptor-mediated portion of the pathway is more likely to function within the expected range. That may support more typical signaling related to testosterone production in males and ovulation, luteal function, and ovarian steroid hormone production in females. Even so, reproductive and sexual health are influenced by many variables beyond a single receptor variant, including age, thyroid status, insulin sensitivity, sleep, stress, energy balance, and broader hormonal regulation across the HPG axis. For that reason, the main recommendation for this genotype is to continue supporting endocrine health through foundational habits such as balanced nutrition, regular exercise, adequate recovery, good sleep, and attention to key reproductive nutrients. Overall, this genotype suggests that LHCGR is less likely to be a major limiting factor in how the body responds to LH-related signaling within the gonadorelin pathway.

Inconclusive — No Result

Your genetic data for rs2293275, a LHCGR gene variant, was not successfully called by the laboratory. This means the test did not detect a reliable result for this position, which can occur for technical reasons such as low signal intensity, DNA quality issues, or limitations of the genotyping array. Without a result, we cannot determine whether you carry the typical or effect variant for this gene. If this information is important for your health decisions, you may wish to consider retesting or confirming this variant through a targeted genetic test or sequencing method.

When to Talk to Your Healthcare Provider

If you have concerns related to reproductive health, the Gonadorelin pathway, or how your LHCGR rs2293275 results fit into your broader health picture, consult your healthcare provider. They can interpret your genetic results alongside your symptoms, health history, and lab values to guide appropriate testing, dietary adjustments, and supplementation where relevant.

PlexusDx provides genetic insights to help you understand how your genes may influence nutrient needs and biological pathways. This information is provided for educational and wellness purposes only and does not diagnose, treat, or recommend any specific medication, peptide, or therapy, some of which may be prescription-only, investigational, or intended for research use only. Always consult with a qualified healthcare provider before making changes to your supplement regimen, diet, or health plan based on genetic information.

Frequently Asked Questions About LHCGR rs2293275 and Gonadorelin

What does the LHCGR rs2293275 variant mean for my reproductive health?

The rs2293275 variant in the LHCGR gene may influence how efficiently biological processes connected to Gonadorelin and Reproductive Health function in your body. Depending on your genotype, this can have a modest to meaningful effect on hormonal regulation, fertility signaling, and reproductive resilience. Understanding your result gives you a personalized starting point for a targeted lifestyle and nutrition strategy grounded in your unique genetic biology.

How does the Gonadorelin pathway relate to LHCGR and reproductive health?

Gonadorelin is a peptide being studied for its potential role in supporting hormonal balance, reproductive function, and endocrine health. Researchers are interested in how Gonadorelin-associated pathways may interact with genes like LHCGR, which contribute to the signaling environments that influence reproductive health function. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150 genetic insights — including LHCGR rs2293275 — to provide a comprehensive view of how your genetics may influence these interconnected systems.

Can lifestyle changes support LHCGR function regardless of my genotype?

Yes. Consistent lifestyle habits — regular exercise, quality sleep, anti-inflammatory nutrition, and stress management — support reproductive health-related biological pathways across all genotypes. For carriers of the effect allele at rs2293275, these habits tend to produce a stronger measurable return because they directly reinforce the signaling environments where this variant has its greatest influence. Consistency and habit stacking — combining exercise, sleep, and nutrition improvements together — tends to produce better outcomes than any single change in isolation.

What tests can help me learn more about my reproductive health and the Gonadorelin pathway?

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150 genetic insights — including LHCGR rs2293275 — to deliver a comprehensive picture of how your genetics may influence peptide-related health pathways. The Peptide Pathways Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

📄 Genetic Report:

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.